Abstract
Pharmacological treatment of hypertension continues to be the most effective and perhaps only practical management of hypertension. There is a rising tide of sentiment in this country for managing hypertension and other chronic diseases with diet, exercise, and a variety of behavioral modification techniques, including relaxation response, biofeedback, and transcendental meditation to the exclusion of drugs. There is no convincing evidence from well-controlled studies that any of these various techniques have a permanent or prolonged antihypertensive effect (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shapiro, A.P., Schwartz, G.E., Ferguson, D.C.E. et al.: Behavioral methods in the treatment of hypertension: a review of their clinical status. Ann. Intern Med. 86: 626, 1977.
Hunt, J.C., Margie, J.D.: The influence of diet on hypertension management. Hypertension Update: Mechanisms, Epidemiology, Evaluation, Management. Editorial Board of Dialogues in Hypertension. Bloomfield, New Jersey, Health Learning Systems, 1980, p. 197.
Reisin, E., Abel, R., Modan, M. et al.: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 2 98: 1, 1978.
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA, 202: 1028, 1967.
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic pressure averaging 90 through 114 mm Hg. JAMA, 213: 1143, 1970.
Five-year findings of the Hypertension Detection and Follow-up Program. JAMA 242: 2562, 1979.
The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet, June 14, 1261, 1980.
The 1980 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch. Intern. Med., 140: 1280, 1980.
Mitchell, H.C., Graham, R.M. and Pettinger, W.A.: Renal function during long-term treatment of hypertension with Minoxidil: Comparison of benign and malignant hypertension. Ann. Int. Med. 93: 676, 1980.
Pettinger, W.A.: Minoxidil and the Treatment of Severe Hypertension. N. Eng. J. Med. 303: 922, 1980.
Brunner, H.R., Gabars, H., Waeber, B. et al.: Oral angiotensinconverting enzyme inhibitor in long-term treatment of hypertensive patients. Ann. Int. Med. 90: 19, 1979.
Bravo, E., Tarazi, R.C.: Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1: 39, 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publisher, The Hague
About this chapter
Cite this chapter
Perez-Stable, E., Materson, B.J. (1982). Pharmacotherapy of Hypertension. In: Strauss, J. (eds) Hypertension, Fluid-Electrolytes, and Tubulopathies in Pediatric Nephrology. Developments in Nephrology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7541-5_21
Download citation
DOI: https://doi.org/10.1007/978-94-009-7541-5_21
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7543-9
Online ISBN: 978-94-009-7541-5
eBook Packages: Springer Book Archive